PharmaEssentia to Present Six Posters at Myeloproliferative Neoplasms Congress

PharmaEssentia USA announced six poster presentations at the 18th International Congress on Myeloproliferative Neoplasms. The headline says the presentations will address unmet needs with current therapies and real-world use of BESREMi in essential thrombocythemia and polycythemia vera.